Go to article
Posted by CoV Report on September 23, 2021 4:40 pmTags: Categories: US National Stories
The advisory committee’s recommendation expands on the FDA’s authorization of Pfizer vaccine boosters for people 65 and up. Both regulatory moves will inform the U.S. plan to dispense extra doses.
(Image credit: Matt Rourke/AP)
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply